Brainstorm Cell Therapeutics Inc. (BCLI) gained 5.45% or 0.17 to $3.29. It is near 24672 shares traded, which is 52.6% compare to the average total volume 46902. The market cap of BCLI is $62.74 million. The year to date change is -14.52%. The 52 week price range is from $2.88 to $5.18. Price of BCLI have changed 1.30% during last week. It have changed -5.74% over last month, -12.85% over last 3 months, -23.72% over last 6 months and -30.20% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for BCLI is 3.30. It is 0.30% above current price. The stock faces resistance at 50-day moving averages. The 200-day Moving Averages for BCLI is 3.91. It is 18.84% above current price. The 52-week High is 5.18. It is 57.45% from the current price. The 52-week Low is 2.88. It is -12.46% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of BCLI is 28.87 on 2018-03-15. Short % to float is 8.59%. There are some statistics of BCLI. It is has market cap $62.74 million. The share outstanding is 19.07 million. The average volume is 46902. The percent of top 15 Institution holding is 9.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of BCLI is -62.76%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of BCLI is -44.63%.